CO4890847A1 - Compuestos de piridiloxi - Google Patents

Compuestos de piridiloxi

Info

Publication number
CO4890847A1
CO4890847A1 CO97034431A CO97034431A CO4890847A1 CO 4890847 A1 CO4890847 A1 CO 4890847A1 CO 97034431 A CO97034431 A CO 97034431A CO 97034431 A CO97034431 A CO 97034431A CO 4890847 A1 CO4890847 A1 CO 4890847A1
Authority
CO
Colombia
Prior art keywords
compound
formula
hydrogen
piridiloxi
compounds
Prior art date
Application number
CO97034431A
Other languages
English (en)
Spanish (es)
Inventor
Steven Mark Bromidge
Ian Thomson Forbes
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of CO4890847A1 publication Critical patent/CO4890847A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CO97034431A 1996-06-20 1997-06-20 Compuestos de piridiloxi CO4890847A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9612883.0A GB9612883D0 (en) 1996-06-20 1996-06-20 Novel compounds

Publications (1)

Publication Number Publication Date
CO4890847A1 true CO4890847A1 (es) 2000-02-28

Family

ID=10795575

Family Applications (1)

Application Number Title Priority Date Filing Date
CO97034431A CO4890847A1 (es) 1996-06-20 1997-06-20 Compuestos de piridiloxi

Country Status (33)

Country Link
US (1) US6369060B1 (enExample)
EP (1) EP0912554B1 (enExample)
JP (1) JP2000512306A (enExample)
KR (1) KR20000022045A (enExample)
CN (1) CN1229408A (enExample)
AP (2) AP9801410A0 (enExample)
AR (1) AR008243A1 (enExample)
AT (1) ATE228514T1 (enExample)
AU (1) AU718597B2 (enExample)
BG (1) BG103089A (enExample)
BR (1) BR9709911A (enExample)
CA (1) CA2258240A1 (enExample)
CO (1) CO4890847A1 (enExample)
CZ (1) CZ420598A3 (enExample)
DE (1) DE69717449T2 (enExample)
DZ (1) DZ2250A1 (enExample)
EA (1) EA001780B1 (enExample)
ES (1) ES2187783T3 (enExample)
GB (1) GB9612883D0 (enExample)
HU (1) HUP9903439A3 (enExample)
ID (1) ID19433A (enExample)
IL (1) IL127417A0 (enExample)
MA (1) MA24214A1 (enExample)
NO (1) NO985972L (enExample)
NZ (1) NZ333229A (enExample)
OA (1) OA10944A (enExample)
PE (1) PE86698A1 (enExample)
PL (1) PL330796A1 (enExample)
SK (1) SK282706B6 (enExample)
TR (1) TR199802661T2 (enExample)
TW (1) TW382015B (enExample)
WO (1) WO1997048699A1 (enExample)
ZA (1) ZA975415B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999043650A2 (en) * 1998-02-25 1999-09-02 Smithkline Beecham Plc Process(es) for the preparation of 6-trifluoromethyl-indoline derivatives
GB0019950D0 (en) * 2000-08-12 2000-09-27 Smithkline Beecham Plc Compounds
JP2005535560A (ja) * 2001-11-28 2005-11-24 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 治療用の化合物
MXPA04008517A (es) * 2002-03-04 2005-08-19 Pharmacia & Upjohn Co Llc Compuestos terapeuticos.
KR101062376B1 (ko) * 2008-04-10 2011-09-06 한국화학연구원 신규 인돌 카르복실산 비스피리딜 카르복사마이드 유도체,이의 제조방법 및 이를 유효성분으로 함유하는 조성물
CN102348798A (zh) 2009-01-16 2012-02-08 麻省理工学院 孤独症谱系障碍的诊断和治疗
EP2651403B1 (en) 2010-12-17 2020-12-02 Glaxo Group Limited Use of lp-pla2 inhibitors in the treatment and prevention of eye diseases
WO2014046544A1 (en) 2012-09-21 2014-03-27 Aapa B.V. Substituted 3-heteroaryloxy-3-(hetero)aryl-propylamines as serotonin transporter and serotonin ht2c receptor modulators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989001333A1 (en) * 1987-08-07 1989-02-23 The Australian National University IMIDAZO[1,2-b]PYRIDAZINES
CA2142721A1 (en) * 1992-08-20 1994-03-03 Ian T. Forbes Condensed indole derivatives as 5ht and 5ht antagonists
GB9313913D0 (en) * 1993-07-06 1993-08-18 Smithkline Beecham Plc Novel compounds
NZ301265A (en) 1995-02-02 1998-12-23 Smithkline Beecham Plc Indole derivatives as 5ht receptor antagonists, preparation and pharmaceutical compositions thereof
GB9607219D0 (en) * 1996-04-04 1996-06-12 Smithkline Beecham Plc Novel compounds
GB9615767D0 (en) * 1996-07-26 1996-09-04 Smithkline Beecham Plc Novel treatment

Also Published As

Publication number Publication date
AP745A (en) 1999-04-28
KR20000022045A (ko) 2000-04-25
CN1229408A (zh) 1999-09-22
MA24214A1 (fr) 1997-12-31
CA2258240A1 (en) 1997-12-24
AP9801410A0 (en) 1998-12-31
CZ420598A3 (cs) 1999-06-16
EP0912554A1 (en) 1999-05-06
NZ333229A (enExample) 2000-01-28
AP9701037A0 (en) 1997-07-31
BR9709911A (pt) 1999-08-10
HUP9903439A3 (en) 2002-12-28
DE69717449T2 (de) 2003-10-02
ID19433A (id) 1998-07-09
TW382015B (en) 2000-02-11
ZA975415B (en) 1998-12-21
OA10944A (en) 2003-02-27
ES2187783T3 (es) 2003-06-16
GB9612883D0 (en) 1996-08-21
AR008243A1 (es) 1999-12-29
PE86698A1 (es) 1999-01-28
BG103089A (en) 1999-09-30
DE69717449D1 (de) 2003-01-09
PL330796A1 (en) 1999-06-07
SK282706B6 (sk) 2002-11-06
SK175298A3 (en) 1999-05-07
JP2000512306A (ja) 2000-09-19
EP0912554B1 (en) 2002-11-27
EA001780B1 (ru) 2001-08-27
EA199900043A1 (ru) 1999-06-24
AU718597B2 (en) 2000-04-20
DZ2250A1 (fr) 2002-12-18
HUP9903439A2 (en) 2000-07-28
TR199802661T2 (xx) 1999-03-22
IL127417A0 (en) 1999-10-28
WO1997048699A1 (en) 1997-12-24
ATE228514T1 (de) 2002-12-15
AU3260297A (en) 1998-01-07
US6369060B1 (en) 2002-04-09
NO985972D0 (no) 1998-12-18
NO985972L (no) 1998-12-18

Similar Documents

Publication Publication Date Title
ATE216360T1 (de) Sulfinsäurederivate und deren herstellung und verwendung
PT88992A (pt) Processo para a preparacao de compostos contendo fosforo uteis como inibidores de colagenase
BR0206433A (pt) Composto, composição farmacêutica, processo para a prepapação de um composto, e, uso de um composto
MX9302169A (es) Fenoxialquilisoxazolas de 1,2,4-oxadiazolilo y su uso como agentes antivirales.
SE8404712D0 (sv) Azole derivatives, process for their production compositions containing them and their use
EA199800109A1 (ru) Производные азетидинона для лечения атеросклероза
DE3583872D1 (de) Dihydropyridin-derivate, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische zusammensetzungen, und verfahren zur herstellung dieser zusammensetzungen.
ES8307718A1 (es) "procedimiento de preparar amidoaminoacidos y similares".
ATE489356T1 (de) Asymmetrischer kupferkomplex und dessen verwendung in cyclopropanierungsreaktion
ATE388957T1 (de) Herstellung von siliziumverbrückten metallocenverbindungen
CO4950614A1 (es) Antagonistas de taquiquinina
DE50108172D1 (de) Verfahren zur herstellung von spirocyclischen tetronsäurederivaten
ES2063879T3 (es) Compuestos triacinicos.
DE3889772D1 (de) Verfahren zur Herstellung von 3,3-Diarylacrylsäureamiden.
ES8505994A1 (es) Un metodo para preparar 2(1h)-piridinonas
DE59712632D1 (de) Verfahren zur herstellung von 3-pyrrolin-2-carbonsäure-derivaten
ATE171936T1 (de) Salpetersäureester von 2-(2,6-dihalophenylamino) phenylacetoessigsäurederivaten und verfahren zu ihrer herstellung
EP0169009A3 (en) Novel dihydropyridine derivatives and their production, formulation and use as pharmaceuticals
EA200000924A2 (ru) СПОСОБ ПОЛУЧЕНИЯ ПИРАЗОЛО[4,3-d]ПИРИМИДИН-7-ОН-3-ПИРИДИЛСУЛЬФОНИЛЬНЫХ СОЕДИНЕНИЙ И ИХ ПРОМЕЖУТОЧНЫХ СОЕДИНЕНИЙ
DE60043228D1 (de) Herstellungsverfahren von 2-cyanopyridinen
EP1028721A4 (en) N, N'-BIS (SULFONYL) HYDRAZINES FOR USE AS ANTINEOPLASTIC AGENTS
ES2096066T3 (es) Procedimiento de desdoblamiento de hidantoinas quirales.
DE59803194D1 (de) Verfahren zur herstellung von 1,3-disubstituierten 2-nitroguanidinen
DE50210377D1 (de) Verfahren zur herstellung von bis (trifluormethyl)imido-salzen
ATE76067T1 (de) Dihydropyridinether, verfahren zu ihrer herstellung und ihre verwendung.